# Niki BioSolutions, Inc. (NIKI)

> Source: Nexqual · https://nexqual.com/NIKI · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, Niki BioSolutions, Inc. (NIKI), nexqual.com/NIKI" · informational, not investment advice.

**Price:** USD 1.83 (-5.67% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 1.94 · day 1.81–1.87 · 52w 1.81–17.2 · market cap $5.7M · NCM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -87.7% vs S&P 500 +13.4%; 5Y -99.2% vs S&P 500 +76.9%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -87.7% | -99.2% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -87.8% | -62.4% |
| Volatility (annualized) | 96.8% | 129.5% |
| Max drawdown | -88.7% (Nov 2025→Oct 2026) | -99.3% (Nov 2021→Oct 2026) |

## Peers (Biotechnology)
LGND (Ligand Pharmaceuticals Incorpor) USD 303.53 -1.39% · RYTM (Rhythm Pharmaceuticals, Inc.) USD 89.27 -1.79% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.09 -0.35% · PRAX (Praxis Precision Medicines, Inc) USD 252.96 -2.30% · IONS (Ionis Pharmaceuticals, Inc.) USD 42.93 -2.23% · AXSM (Axsome Therapeutics, Inc.) USD 145.04 -7.07%

## More
Full page: https://nexqual.com/NIKI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in NIKI's own 20-F filed 2026-03-27 (https://www.sec.gov/Archives/edgar/data/1734005/000121390026035484/ea0281612-20f_aptorum.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Versitech | "Accordingly, Versitech is the only active license agreement we have at this time." |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends 2023-12-31) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |